INTERNIS PHARMACEUTICALS LIMITED
Internis Pharmaceuticals develops, manufactures, and supplies prescription vitamin D medicines for the United Kingdom market.
Enterprise value
$65m
Company register number
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
£49.0m Valuation: £49.0m 2.8x EV/Revenue 6.8x EV/EBITDA | Acquisition | ||
| Total Funding | 000k | ||
Norgine Ventures(exited)
| GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 29 % | (13 %) | (7 %) | 12 % | (5 %) | 7 % | (6 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 48 % | 31 % | 24 % | 36 % | 44 % | 45 % | 30 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 38 % | 26 % | 17 % | 28 % | 29 % | 38 % | 23 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads